Reports
Reports
Gauge Marketability Across Various Therapeutic Areas
Total Reports: 400
The ophthalmic drug market is currently witnessing robust growth because of increased prevalence of eye diseases, advancements in pharmaceutical technology, and enhanced global awareness of the importance of eye care. One of the major reasons for this market expansion is rise in the prevalence of eye disorders.
Rep Id : TMRGL1769 | Published | Pharmaceutical | July 2025
The pain management therapeutics market is poised for steady growth, owing to increasing prevalence of chronic pain conditions including arthritis, neuropathic pain, and pain related to cancer – particularly in aging population. North America has the most advanced market due to it being home to established healthcare delivery systems and
Rep Id : TMRGL1059 | Published | Pharmaceutical | July 2025
The market for addiction treatment has expanded significantly over the last two years due to heightened awareness of addiction disorders as well as the wider variety of available treatments. As society's stigma over addiction lessens, more number of patients are seeking the services of the market, which, in turn, is
Rep Id : TMRGL40199 | Published | Pharmaceutical | July 2025
The global psoriasis treatment market is witnessing steadiness, driven primarily by the increase in prevalence of psoriasis, rising awareness and advancements in biologic and targeted therapies. More number of patients are being diagnosed with psoriasis due to the overall increase in healthcare access and improved awareness, which increases the demand
Rep Id : TMRGL17960 | Published | Pharmaceutical | July 2025
The biologics marketplace is growing on an unprecedented note due to visible demand for targeted therapies in conjunction with advancements in biotechnology. Biologics are complex drugs derived from living cells that provide a high level of specificity as well as effectiveness for chronic disease treatment.
Rep Id : TMRGL15509 | Published | Pharmaceutical | July 2025
The active pharmaceutical ingredients (API) market is witnessing a robust growth. This could be attributed to increase in healthcare spending, growing incidences of infectious and chronic diseases, and rising demand for innovative and generic medicines.
Rep Id : TMRGL1690 | Published | Pharmaceutical | May 2025
Development of innovative delivery technologies and advancements in medical expertise are expected to fuel the peptide therapeutics market size. PEGylation is a popular trend in the peptide drug chemical structure, which improves pharmacologic properties by increasing half-life, reducing antigenicity and immunogenicity, and improving solubility.
Rep Id : TMRGL418 | Published | Pharmaceutical | April 2025
The global acute kidney injury treatment market was valued at US$ 3.6 Bn in 2024 and is projected to reach US$ 8.2 Bn by 2035, registering a CAGR of 7.8% from 2025 to 2035. The market is driven by the growing incidence of kidney injuries due to rise in the
Rep Id : TMRGL67523 | Published | Pharmaceutical | April 2025
The market for stroke therapy as growth-promoting, driven by advancements in pharmacologic therapy and a better understanding of stroke pathophysiology. The sector is focusing more on the development of thrombolytic and antiplatelet medications, pivotal in acute stroke treatment for ischemic strokes. Drug delivery systems and formulation science are aiming at
Rep Id : TMRGL73917 | Published | Pharmaceutical | March 2025
Increase in awareness among healthcare professionals and patients regarding rare conditions such as alkaptonuria, ongoing technological advancements in genetic research, rising investments in research and development initiatives, and collaborative regulatory environment are the factors fueling the global alkaptonuria therapeutics market trajectory. Progress in bioanalytical assays and genetic testing has enabled
Rep Id : TMRGL86459 | Published | Pharmaceutical | February 2025
Increased funding for R&D activities coupled with grants by government and non-government agencies regarding rare diseases (including nephropathic cystinosis) is crucial to changing the treatment landscape. This rise in financial resources lends great power to the efforts being made to develop new and effective treatments.
Rep Id : TMRGL32210 | Published | Pharmaceutical | August 2024
Growth in customer desire for natural and plant-derived components, especially in nutritional supplements and digestive health products, is bolstering the bromelain market growth. Bromelain, an enzyme extracted from pineapples, is widely utilized in the food industry due to its potent proteolytic activity.
Rep Id : TMRGL65423 | Published | Pharmaceutical | August 2024
Advances in biotechnology and better understanding of human microbiome is fueling the live biotherapeutics market growth.
Rep Id : TMRGL86353 | Published | Pharmaceutical | July 2024
Rise in geriatric population and influx of biologics are augmenting the paroxysmal nocturnal hemoglobinuria market demand. Paroxysmal nocturnal hemoglobinuria (PNH) is a chronic disorder affecting nearly 20,000 people across the globe.
Rep Id : TMRGL86343 | Published | Pharmaceutical | July 2024
The paresthesia treatment industry growth is slated to be witnessed based on rise in the number of patients suffering from neurological disorders along with adoption of technological advancements to combat the same.
Rep Id : TMRGL66734 | Published | Pharmaceutical | July 2024
Rise in the number of patients battling bad cholesterol is the factor augmenting the PCSK9 inhibitor market opportunities. Increase in incidence of cardiovascular diseases is another factor catalyzing the PCSK9 modulators landscape.
Rep Id : TMRGL83528 | Published | Pharmaceutical | July 2024
Increase in incidence of pancreatic cancer is the factor basically responsible for the growth of pancreatic cancer treatment market. Various technological advancements are being adopted to devise effective medications for pancreatic cancer, with radiation therapy being one of them.
Rep Id : TMRGL86342 | Published | Pharmaceutical | July 2024
Growing investment as well as funding by governments and non-government agencies worldwide to exercise control over opioid overdose is the factor basically responsible for the growth of opioid use disorders market.
Rep Id : TMRGL75167 | Published | Pharmaceutical | July 2024
Easy administration and wider patient compliance are responsible for the growth of the oral solid dosage pharmaceutical formulation market. Moreover, lesser cost associated with the production and dispersion of these formulations makes them viable for the patients.
Rep Id : TMRGL80675 | Published | Pharmaceutical | July 2024
The global non-muscle invasive bladder cancer market is slated to grow noticeably on the basis of rise in the number of patients suffering from non-muscle invasive bladder cancer along with governments extensively investing in qualitative research pertaining to therapeutics for non-muscle invasive bladder cancer.
Rep Id : TMRGL86334 | Published | Pharmaceutical | July 2024
The global non-insulin therapies for diabetes market is slated to grow on an exponential note with a sizable increase in incidence of type 2 diabetes followed by governments and non-government agencies collaborating to devise better measures to cure it, with non-insulin therapies being the epicenter.
Rep Id : TMRGL86328 | Published | Pharmaceutical | July 2024
Rise in incidence of cardiovascular diseases and insomnia are the factors responsible for the augmentation of nocturia market. Various conditions affecting the bladder/prostate can result in having to wake up to urinate.
Rep Id : TMRGL49929 | Published | Pharmaceutical | July 2024
The global neuroregeneration therapy market is slated to grow on an exponential note due to rise in the incidence of neurological disorders followed by extensive R&D activities being witnessed on the therapeutics count.
Rep Id : TMRGL86322 | Published | Pharmaceutical | July 2024
Rise in the incidence of chronic diseases is the factor basically augmenting the natural APIs market. Active pharmaceutical ingredients (APIs) play a crucial role in human therapeutics, as they account for close to 20% of secondary metabolites.
Rep Id : TMRGL86321 | Published | Pharmaceutical | July 2024
Rise in the number of patients suffering from myocarditis is the factor basically responsible for the growth of myocarditis treatment market. Myocarditis is referred to as inflammation of heart muscle caused owing to autoimmune diseases.
Rep Id : TMRGL86316 | Published | Pharmaceutical | July 2024
Rise in incidences of chronic respiratory and nasal disorders is responsible for the expansion of nasal corticosteroids market size. A nasal corticosteroid helps in simplifying breathing through nose. It is sprayed into the nose for reducing symptoms such as nasal stuffiness.
Rep Id : TMRGL86315 | Published | Pharmaceutical | July 2024
The global naltrexone market is slated to grow on an exponential note due to increase in the incidence of autoimmune diseases and more number of people getting addicted to alcohol and opioids.
Rep Id : TMRGL64916 | Published | Pharmaceutical | July 2024
The global nasal polyposis treatment market is slated to grow exponentially due to continuous launch of new products by the key players followed by increase in the number of retail pharmacies providing these drugs. Nasal polyposis, also called nasal polyps, are pink or yellowish in color and hang down, resembling
Rep Id : TMRGL53529 | Published | Pharmaceutical | July 2024
Increase in the number of patients suffering from meningitis and sizable research conducted regarding the medications offered in this regard are the factors holding the responsibility of augmentation of meningitis treatment market.
Rep Id : TMRGL86291 | Published | Pharmaceutical | July 2024
Increase in preference for gene therapy and substrate reduction therapy are majorly holding the responsibility of driving the metachromatic leukodystrophy treatment market. Metachromatic leukodystrophy ends up adversely affecting the nervous system to the extent of the body not being able to perform the daily chores. Timely detection and treatment can
Rep Id : TMRGL77187 | Published | Pharmaceutical | July 2024
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science - a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
